NCT01595113已完成不适用
A Follow-up Observational Study of Safety of Clinical Trial Conducted With Cell Transplant Therapy Using Hearticellgram-AMI for Patients With Acute Myocardial Infarction
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 41
研究概览
简要总结
The purpose of this study is to evaluate the safety of the previously conducted clinical trial cell transplant therapy using Hearticellgram-AMI for patients with acute myocardial infarction. This is a follow-up observational study and targeting the subjects who participated in the previously conducted clinical trial.
详细描述
The safety evaluation in this clinical trial is performed with variables, such as occurrence and severity of adverse events, clinical laboratory tests, vital signs, physical examination, cardiac events, and cancer.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who have elapsed for more than 2 years after onset of acute myocardial infarction among the patients who had received cell transplant therapy or drug treatment at least once in test and control group on the previously conducted clinical trial.
- •Subjects agreed to participate in this follow-up study and signed the consent form.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus NephritisLupus NephritisNCT04522505Corestemchemon, Inc.6
进行中（未招募）
不适用
A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-501Homozygous Familial Hypercholesterolemia (HoFH)NCT04080050REGENXBIO Inc.8
已完成
不适用
Celotres for Improvement in Wound Healing and Resulting Scar Consequences Following Suturing of a WoundScarNCT01706848Halscion, Inc.60
终止
不适用
Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin StudiesCerebrovascular DisordersCardiovascular DiseaseNCT00452842Pfizer26,784
招募中
不适用
An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac ArrhythmiasNCT04750798Biosense Webster, Inc.8,000